IJCRR - 8(6), March, 2016
BIOCHEMICAL ASSESSMENT OF HOMOCYSTEINE AND LIPID PROFILE IN PEDIATRIC STROKE: AN EGYPTIAN STUDY
Author: Tahia H. Saleem, Mohammed H. Hassan, Ahmed El-Abd Ahmed, Abdallah M. A.A. El-Ebidi, Heba M. Qubaisy, Omayma A. Hasan
Introduction: Stroke and cerebrovascular disorders are already amongst the top 10 causes of childhood death. Patients with homocysteinemia may present with vascular thrombotic events, with or without the traditional risk factors for a stroke. Objectives: The aim of this study was to measure plasma homocysteine levels and lipid profile (serum cholesterol, triglycerides, HDL and calculation of LDL) in pediatric patients with ischemic or hemorrhagic stroke. Assess the role of homocysteinemia as an associated risk factor in pediatric ischemic stroke. Correlate the results with the clinical data of the patients. Materials and Methods: Across-sectional case control study was carried out on 60 pediatric patients, divided into two groups: group A contained 30 pediatric patients with ischemic stroke and group B contained 30 pediatric patients with hemorrhagic stroke, they were recruited from outpatient clinics or admitted to PICU (pediatric intensive care unit) in Assiut university children hospital and Qena university hospital, Upper Egypt, after approval of the university hospital ethical committee. The control group “group C” contained 30 healthy age and sex matched subjects. Biochemical assay of plasma homocysteine and lipid profile among the previously mentioned groups were done. Results: The plasma homocysteine level showed statistically significantly higher levels among group A when compared with group B and group C (P-Value 0.0001). There was no significant difference in plasma homocysteine among group B when compared with group C (P-Value 0.9). Regarding the lipid profile assay in the studied groups, serum triglyceride level, cholesterol and low density lipoprotein (LDL) were significantly high among group A in comparison with group B and group C (P-Value<0.0001), while high density lipoprotein (HDL) level was significantly low among group A in comparison with group B and group C( PValue<0.0001). There was a positive correlation between plasma homocysteine level and both LDL and triglyceride levels while a negative correlation between plasma homocysteine level and HDL level. Conclusion: Elevated plasma homocysteine can be considered as an associated risk factor among pediatric patients with ischemic stroke that could be explained by its atherogenic and thrombotic effects. This was associated with hyperlipidemia.
Keywords: Homocysteine, Lipid profile, Pediatric stroke, Egyptian study
Tahia H. Saleem, Mohammed H. Hassan, Ahmed El-Abd Ahmed, Abdallah M. A.A. El-Ebidi, Heba M. Qubaisy, Omayma A. Hasan. BIOCHEMICAL ASSESSMENT OF HOMOCYSTEINE AND LIPID PROFILE IN PEDIATRIC STROKE: AN EGYPTIAN STUDY International Journal of Current Research and Review. 8(6), March, 22-29
1. Neil F. Pediatric Stroke: Past, Present and Future. Advances in Pediatrics 2009; 56: 271–299.
2. Sharmini R. Arterial ischemic stroke in childhood. Pediatrics and Child Health 2014; 24:462-467.
3. Timothy J, Warren L and Mark T. Towards a consensus-based classification of childhood arterial ischemic stroke. Stroke 2012; 43:371-377.
4. Jonathan H, Daniel S. Pediatric stroke: a review. Emergency Medicine International 2011:1–10.
5. Djuric D, Jakovljevic V, Rasic-Markovic1 A, Djuric A, Stanojlovic O. Homocysteine, folic acid and coronary artery Disease: Possible Impact on Prognosis and Therapy. The Indian Journal of Chest Diseases and Allied Sciences 2008; 50: 39-48.
6. Richard E, Desviat L, Ugarte M, Pérez B. Oxidative stress and apoptosis in homocystinuria patients with genetic remethylation defects. J Cell Biochem 2013; 114(1):183-91.
7. Antoniades C, Alexios S. Antonopoulos, Dimitris T, Kyriakoula M, Christodoulos S. Homocysteine and coronary atherosclerosis: from folate fortification to the recent clinical trials. European Heart Journal 2009; 30: 6–15
8. Lawrence de Koning A, Geoff H, Richard C. Hyperhomocysteinemia and its role in the development of atherosclerosis. Clinical Biochemistry 2003; 36:441–431.
9. Friedewald W, Levy R, Fredrickson D. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem 1972; 18 (6): 499-502.
10. DeVeber G. In pursuit of evidence-based treatments for pediatric stroke: the UK and Chest guidelines. The Lancet Neurology 2005; 4(7):432–436.
11. Ogeng’o J, Olabu B, Mburu A, Sinkeet S. Pediatric stroke in an African country. Journal of pediatric neurosciences 2010; 5(1): 22-24.
12. Chung B, Wong V. Pediatric stroke among Hong Kong Chinese subjects. Pediatrics 2004;114(2): 206–212.
13. Salih M, Abdel-Gader A, Al-JarallahA. Infectious and inflammatory disorders of the circulatory system as risk factors for stroke in Saudi children. Saudi Medical Journal 2006; 27(1): 41–52.
14. Kalita J, Goyal G, Misra U. Experience of pediatric stroke from a tertiary medical center in North India. Journal of the neurological sciences 2013; 325(1): 67-73.
15. Saima B, Gilani S, Shah S, Siddiqui T: Childhood strokes: epidemiology, clinical features and risk factors. J Ayub Med Coll Abbottabad 2011; 23(2): 69-71.
16. Parakh M, Arora V, Khilery B. A Prospective Study Evaluating the Clinical Profile of Pediatric Stroke in Western Rajasthan. Journal of Neurological Disorders 2014; 2 (6) :1-4.
17. Vijaya B, Vennela D, Suma P. Study of homocysteine, lipoprotein (a) and lipid profile in ischemic stroke. Sch. J. App. Med. Sci. 2014; 2(4):1247-1250.
18. Ashjazadeh N, Fathi M, ShariatA. Evaluation of homocysteine level as a risk factor among patients with ischemic stroke and its subtypes. Iranian journal of medical sciences 2013; 38(3): 233-9.
19. Narang A, Verma I, Kaur S, Narang A, Gupta S, Avasthi G . Homocysteine- Risk factor for ischemic stroke?Indian J PhysiolPharmacol 2009; 53(1): 34-8.
20. García S, Concepción O, Carriera R, Zuaznábar M. Association between Blood Lipids and Types of Stroke. MEDICC Review 2008; 10(2): 27-32.
21. Xiao Y, Zhang Y, Lv X, et al. Relationship between lipid profiles and plasma total homocysteine, cysteine and the risk of coronary artery disease in coronary angiographic subjects. Lipids in Health and Disease 2011; 10(137): 1476-511.
22. Elshorbagy A, Nurk E, Gjesdal C, Tell G, Ueland P, Nygård O, Refsum H. Homocysteine, cysteine, and body composition in the HordalandHomocysteine Study: does cysteine link amino acid and lipid metabolism?.The American journal of clinical nutrition 2008; 88(3): 738-746.
23. El-Khairy L, Ueland P, Refsum H, Graham I, Vollset S . Plasma total cysteine as a risk factor for vascular disease The European Concerted Action Project. Circulation 2001; 103(21): 2544- 2549.